Understanding how added sugar warnings on restaurant menus affect what people choose to eat
A large-scale quasi-experimental evaluation of added sugar warning labels in restaurants
['FUNDING_R37'] · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · NIH-11129885
This project looks at whether new warning labels for high-sugar items on restaurant menus in New York City help people make healthier food choices.
Quick facts
| Phase | ['FUNDING_R37'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11129885 on ClinicalTrials.gov |
What this research studies
New York City recently started requiring restaurants to put warning labels next to menu items that are high in added sugar. This project wants to find out if these labels actually change what people buy when they eat out. We will compare changes in purchases in NYC before and after the labels were introduced, against other cities without these warnings. The goal is to understand if these warnings help reduce the risk of conditions like obesity and type 2 diabetes.
Who could benefit from this research
Good fit: Individuals who are 21 years or older and regularly purchase food from restaurants, particularly in New York City or similar urban environments, are relevant to this research.
Not a fit: Patients who do not eat at restaurants or are not concerned about their sugar intake may not directly benefit from this specific policy-focused research.
Why it matters
Potential benefit: If successful, this work could show that simple warning labels can help people make healthier food choices, potentially reducing the risk of chronic diseases like type 2 diabetes.
How similar studies have performed: While similar warning models have been successful for cigarettes and beverages, real-world studies on added sugar warnings in restaurants are very limited.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RUMMO, PASQUALE — NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- Study coordinator: RUMMO, PASQUALE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Adult-Onset Diabetes Mellitus